US Medical Head, Dyslipidemia

AstraZeneca•Wilmington, DE

1d•Hybrid

About The Position

The US Head of Medical – Dyslipidemia is a leadership position within AstraZeneca’s BioPharmaceuticals Business Unit, US Medical CVRM franchise. The role reports directly to the VP Medical Cardiovascular Renal Metabolism (CVRM) and leads a team responsible for developing and executing disease-area and brand strategies, as well as driving product launches for a novel oral PCSK9 inhibitor across its life cycle. The position is based in an environment that averages a minimum of three office days per week while allowing individual flexibility. The successful candidate will work across a sophisticated matrix, partnering with commercial, global, and internal and external stakeholders. They will also lead medical initiatives and use AI- and digital-driven analytics, platforms, and clinical solutions to strengthen medical planning, scientific engagement, evidence generation, and patient outcomes.

Requirements

Sophisticated scientific degree (MBBS, PharmD, PhD, or MD) or equivalent education.
At least 7 years of pharmaceutical industry experience, ideally in Medical Affairs and the dyslipidemia space.
At least 5 years of experience leading high-performing teams in the pharmaceutical industry.
Medical, clinical, or scientific expertise in CVRM.
Knowledge of or experience with US regulatory strategy, including new product approval and labeling requirements and negotiations.
Strong business acumen and a comprehensive understanding of the US healthcare environment.

Nice To Haves

Phase 3b/4 and post-approval dedicated research, including leading all aspects of patient registries and REMS programs.
Translational medicine and population-based real-world research.
Experience bridging coordinated care management and quality-improvement pathways.
Understanding of health outcomes research, including patient-reported outcomes.
Experience integrating emerging technologies such as AI-supported insights, machine-learning tools, or digital medical platforms into medical affairs strategies or operational processes.

Responsibilities

Build and lead the dyslipidemia medical team, accountable for developing and executing disease-area and brand strategies and plans.
Manage disease-area and brand budget and resource requirements.
Partner effectively with the Commercial Lead and model teamwork across the enterprise.
Serve as the US point of contact for the Global Product Team (GPT).
Provide the US viewpoint on life-cycle management and Phase IV strategy and study design.
Develop and maintain positive relationships with key external and internal customers.
Anticipate future marketplace trends and needs.
Coach, mentor, and lead the performance of direct reports; contribute to succession and talent management.
Foster a team culture that encourages continued growth and recognition.
Collaborate and build internal and external networks.
Deliver results in a sophisticated matrix environment, build capabilities, and lead large-scale, impactful medical initiatives.
Lead launches of new products.
Leverage AI- and digital-driven analytics, platforms, and clinical solutions to improve medical planning, scientific engagement, evidence generation, and patient outcomes.
Ensure compliance with AstraZeneca corporate policies.